About
Harry Kirsch is the Chief Financial Officer of Novartis and a member of the Executive Committee of Novartis. Prior to his current position, he served as CFO of the company's Pharmaceuticals Division. Under his leadership, the division's core operating income margin increased, in constant currencies, every quarter of 2011 and 2012 despite patent expirations. Harry joined Novartis in 2003 from Procter & Gamble in the United States, where he was a CFO of P&G's global pharmaceutical business and held various finance positions at divisional, regional, country, and manufacturing site level, as well as in the P&G Global Business Services organization. Harry also represents Novartis on the board of the GSK Consumer Healthcare joint venture. He holds a degree in Industrial Engineering & Economics from the University of Karlsruhe in Germany.
